States Allege British Drug Company Tried to Keep Generic Suboxone Off the Market

Attorneys general from 35 states and the District of Columbia are suing a British drug company, alleging it tried to keep less expensive generic versions of the opioid addiction treatment Suboxone off the market.

The suit says the drug company, Indivior, was granted exclusive rights in 2002 to sell Suboxone tablets for seven years, Fox News reports. When those rights expired, the suit alleges, Indivior company worked with the New Jersey company MonoSol Rx to make an oral strip form of Suboxone. The strip form was marketed as safer than tablets, according to the suit. MonoSol Rx is also named in the suit.

Full story British drug company keeping Suboxone off the market at

Published by

Will Savage

Quantum Units Continuing Education provides online CEU training's to licensed professional mental health therapists, counselors, social workers and nurses. Our blog provides updates in the field of news and research related to mental health and substance abuse treatment.